SCYNEXIS, Inc. Revenue, Net (Deprecated 2018-01-31)
SCYNEXIS, Inc. (SCYX) reported Revenue, Net (Deprecated 2018-01-31) of $2.31 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2015-05-15
- SCYNEXIS, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $2.31M, a 19.88% decline year-over-year.
- SCYNEXIS, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $3.48M, a 87.74% increase year-over-year.
- SCYNEXIS, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $2.56M, a 9.27% increase year-over-year.
- SCYNEXIS, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $2.82M, a 17.30% increase year-over-year.
- SCYNEXIS, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $11.74M, a 22.65% increase from fiscal 2013.
- SCYNEXIS, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2013 was $9.57M.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2015-03-31 | $2.31M 10-Q · filed 2015-05-15 | $5.79M derived: sum of 2 quarters · filed 2015-05-15 | $8.34M derived: sum of 3 quarters · filed 2015-05-15 | $11.16M derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $6.03M derived: sum of 2 quarters · filed 2015-03-30 | $8.85M derived: sum of 3 quarters · filed 2015-03-30 | $11.74M 10-K · filed 2015-03-30 |
| 2014-09-30 | $2.56M 10-Q · filed 2014-11-13 | $5.38M derived: sum of 2 quarters · filed 2014-11-13 | $8.26M 10-Q · filed 2014-11-13 | $10.11M derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-06-30 | $2.82M 10-Q · filed 2014-08-13 | $5.70M 10-Q · filed 2014-08-13 | $7.55M derived: sum of 3 quarters · filed 2015-05-15 | $9.89M derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-03-31 | $2.88M 10-Q · filed 2015-05-15 | $4.73M derived: sum of 2 quarters · filed 2015-05-15 | $7.08M derived: sum of 3 quarters · filed 2015-05-15 | $9.48M derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $4.19M derived: sum of 2 quarters · filed 2015-03-30 | $6.60M derived: sum of 3 quarters · filed 2015-03-30 | $9.57M 10-K · filed 2015-03-30 |
| 2013-09-30 | $2.34M 10-Q · filed 2014-11-13 | $4.75M derived: sum of 2 quarters · filed 2014-11-13 | $7.72M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $2.40M 10-Q · filed 2014-08-13 | $5.38M 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $2.97M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |